Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled st
about
Active metabolites as antidepressant drugs: the role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disordersAdjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomesSpotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depressionSecond Generation Antipsychotics in the Treatment of Major Depressive Disorder: An UpdateDo Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating OverviewSexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate.Plasma quetiapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2000-2011Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression.Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)Treatment-resistant depression in primary care across CanadaMeta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorderEfficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies.Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression.Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature.Antipsychotics as antidepressants.Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline.The management of schizophrenia: focus on extended-release quetiapine fumarate.Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.Update on extended release quetiapine fumarate in schizophrenia and bipolar disordersAtypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis.Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative studyEarly Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder.A Randomized, Double-blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Major Depressive Disorder.Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A Randomized, Double-Blind Study.A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.Quetiapine extended release: adjunctive treatment in major depressive disorder.The hidden third: improving outcome in treatment-resistant depression.Emerging drugs for major depressive disorder.Augmentation treatments with second-generation antipsychotics to antidepressants in treatment-resistant depression.Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.Burning issues in the meta-analysis of pharmaceutical trials for depression.A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: a European perspective.Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy.The integrative management of treatment-resistant depression: a comprehensive review and perspectives.Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review).Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled TrialsEvidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.
P2860
Q21129108-E615F160-9E1D-4EDC-8493-12CCD5256207Q21144599-4EDC91F5-4C3A-42C8-9D92-22C8F35F1178Q26747833-0353EA43-8D49-46A0-8B24-91F8D52D0BE4Q28076712-8481648A-F023-468C-B313-2B3F7CBFA6BDQ28077687-9A2A7A42-4D56-4F68-940C-6BFB80C7FEAFQ30457019-E2EBBD33-5CB3-4EBB-8114-C557682DD787Q30685511-45E97212-59F6-4412-8E17-B0663A722B23Q31142701-0F728563-963B-4E46-85FB-CB8A9D208EB0Q33837167-49B1FEF0-A834-4B6D-AE27-4A89C411079CQ33861601-AF5720C2-6E27-4932-9AAE-25F17B3448F2Q34010693-75D77C27-226B-47EC-8FFC-E38EB19D332AQ34092254-026BE4F2-9FE1-48FF-B666-ED9C2B9E8ACFQ34122966-0203C0EF-541D-4806-B918-C1FF976D19B9Q34330761-DD73FB15-1D4D-4591-926E-5A0E40482C6EQ34475987-01F9A342-A2D4-440B-8A12-4FEFBDE1F8FAQ35088837-FD062907-B707-4613-9B96-855388C0B4E6Q35327044-8106164A-0932-4133-A317-2FA547DE8F6CQ36091234-DF3105D7-FB70-4914-858E-A8C6DDB331B7Q36393992-790D5C6B-0D22-4BB6-AB4F-65883A34F1F4Q36588685-AEFB9826-A065-47AB-983A-DA3C2A8B29F7Q36769085-BE85D089-F1A9-45CD-9092-F6F65B364226Q36983421-CDD562F7-81A4-445D-AB3E-1BABFD50F08CQ37299884-A06E0D89-84D5-424A-9C21-40D408FE8BDCQ37299893-F89CBCD9-CCC5-494B-A4C3-C804BE287715Q37562207-FE263DF1-E02C-4A17-B24A-712C6BE968D6Q37653402-EE075AA0-0ED0-42C6-BF6B-F98D98DD53ACQ37922769-1CC5F930-7311-4969-B023-3CA405E2267FQ37974998-7D2C80E8-AD2B-4B9A-BC6D-F03A2A7F5B30Q37984619-060235F7-55AD-41FF-A30E-36F80F6EDA3AQ38109589-84146397-C556-45E8-B9D5-97F91AE2D269Q38109590-42873E5F-693F-49FE-AE90-F40863844953Q38123516-2025A1D0-DE9D-46BD-B0F0-7A282BC760E6Q38125219-CD746003-C41C-4125-93E2-C88AE1CBFE17Q38138536-A2F7FECB-A092-49C8-A897-081099064A2AQ38151017-0905F8AB-9064-40D9-947A-C1D6771CE78BQ38157027-A6C76ABA-ED83-47E0-A990-A7026DB9A3B5Q38181363-35F5FDD4-03D4-4ADD-AA80-6ACA22F4D01DQ38350551-0333A42B-4E77-4C05-AFE5-B6399735B8FDQ38377259-739D78D2-375A-4ACD-8A54-42757605705CQ38476909-20FD23E8-3CB6-40AF-8207-72CC0B9AB44B
P2860
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled st
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Extended-release quetiapine fu ...... e-blind, placebo-controlled st
@en
Extended-release quetiapine fu ...... e-blind, placebo-controlled st
@nl
type
label
Extended-release quetiapine fu ...... e-blind, placebo-controlled st
@en
Extended-release quetiapine fu ...... e-blind, placebo-controlled st
@nl
prefLabel
Extended-release quetiapine fu ...... e-blind, placebo-controlled st
@en
Extended-release quetiapine fu ...... e-blind, placebo-controlled st
@nl
P2093
P2860
P1476
Extended-release quetiapine fu ...... e-blind, placebo-controlled st
@en
P2093
Catherine Datto
Hans Eriksson
Mark Joyce
Nizar El-Khalili
Petter Lindgren
Robert J Buynak
Sarah Atkinson
P2860
P304
P356
10.1017/S1461145710000015
P577
2010-02-23T00:00:00Z